CRISPR Gene Therapeutics in Humans

Until recently, gene editing was extremely expensive and took several months, even years. However, with the discovery of CRISPR/Cas-9, costs have shrunk by 99% and tests can be run in days/weeks. Put very simply, the CRISPR/Cas9 technology is effectively a pair of microscissors that cuts DNA in a precise, directed manner. With CRISPR/Cas9, we can go into cells to modify DNA in a way that’s comparable to editing a document. Through this system, we have the potential to switch off the disease-causing mutated version of genes, delete fragments of DNA to treat conditions like Duchenne muscular dystrophy, and insert new genes to produce therapeutically relevant proteins.


Our analyst team reviews an emerging trend with interested listeners — alternating between Healthcare and Agriculture — outlining macro-trends, industry sub-sectors, key influencers, market leaders, and potential investment opportunities. Register here.